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an endothelial dependent vasodllator. Finally, 10 mM sodiumnitrite (an en-
dothelial independent vasodlliator) was added.
The patient group consisted of 37 patients, with a mean age of 61.4
(+ 8.4) years, 27% was female and the mean dilation to ME was 40% (*
24%) of the precontraotion to PE. Linear regreaaion showad that both total
sarum cholesterol (regression coefficient (r.c.)= 10.7%/mmol, p = 0.006) and
Idl-cholesterol (r.c.= 11.5%/mmol, p = 0.01) were predictors for impaired en-
dothelial dependent dilation. Adjusted for several other clinicel characteristics
in a multiple linear regression mcdel, total serum cholesterol was the only
statistically significant predictor of endothelial dysfunction (r.c 10.6%/mmol,
p = O.ooe). Endothelial independent vaaodilation to sodiumnitrite was not
influenced by serUmlipid levels.
Thesa results indicate that total cholesterol is tha best predictor for en-
dothelial dysfunction in IMA’s of coronary bypass patients.
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Tha asacciation between coronary plaqua rupture and risk factors has not
been fully explored. We prospectively examined 164 hearts from man dying
unexpectedly; th,era were 44 sudden coronaty deaths (SCD) with plaque
rupture (age 48 + 9), 53 SCD with stable plaque with or without healed
myocardial infarction (age 53+ 11),16SCDwitherod$d plaques (age46+9)
and 51 non-coronaty deaths (age 49 + 10year$). Heartsware perfusion fixed
at phyalologic pressures and coronay atteries seclioned serially. All areas
of cross sectional Iuminal narrowing z50Y0 were evaluated histologically for
thrombi. Postmortem sera were evaluated for % glycosylatad hemoglobin,
thiocyanate as an indicator for cigarette smoking, total cholesterol (TC), and
high density lipoprotein cholesterol (HDL-C). Mean TC/HDL was 8.5+ 0.6 in
SCD with plaque rupture, exceeding controls (5.0+ 0.3, p < 0.0001), SCD
with stable plaque (5.5 + 0.6, p < 0.0001), and SCD with eroded plaque
(5.0 + 1.9, p = 0.002). By logistic regression, TC/HDL-C was a predictor of
plaque rupture Independent of age, glycosylated hemoglobin, heart weight,
smoking history, and hypertension (p = 0.0008, odda ratio 5.1). These data
suggest that the reduced morbidity and mortality by cholesterol lowering in
primary and secondary prevention is related to the stabilization of plaques
with prevention of plaque rupture.
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How cholesterol (CH) lowering produces clinical benefits, besides the angio-
graphic evidences, it is unknown. In our study on the effects of low density
lipoproteins (LDL)-apheresis in patients with diet and drug reaistant familial
hypercholesterolemia (FH) weaddress$d the specific question if high plasma
CH Ievels’’perse” may adversely affect endothelium adhesiveness and if this
phenomenon might be reversible.
We studied, in 8 FH patients, the acute and after 2 and 6 days effect
of CH removal on plasma intercellular adesion molecule 1 (sICAM1) and
on endothelium leukocyte adhesion molecule 1 (sELAM1). Apolipoprotain
B containing lipoproteins were selectively absorbad on column of destran
sulfate celluloae and during 3.5-4 hours a plasma volume of 6.5-9.2 Iitres
was treated. CH, CH-LDL, apo B, TG and Lp(a), were reduced by 74%,
62%, 79%, 56%, 86%, respectively. No significant effect was observed on
HDL-CH. Clinical chemical and biocompatibilify showad minimal changes.
Basal sICAM1 and sELAMI levels were higher compared to healthy control
subjects; after, and not by, ldl-apheresis theywereconstantlY and significantly
(p <0.0091 and p <0.0004, respectively) reduced. Individual, pre and
poet treatment, valuea of both sICAM1 and sELAM1 were positively and
significantly (p <0.0001 and p <0.02, respectively) correlated with total CH.
Rebound sICAMI and sELAM1 curves showed a pattern similar to that of
total CH but not TG and Lp(a).
In the absence of changes of tumor necrosis factora and factors involved
in inflammation, these results indicate a possible role for CH in regulating
endothelium adhesiveness at least in FH and confirm, in a clinical setting,
the upregulation of endothelium adhesiveness observed in atherogenesis
induced in animal renderad hyperchole$terolemics.
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Restenosis after percutaneouscoronaty angioplasty (PTCA) depends on var-
ious mechanisms such as intimal hyperplasia, elastic recoil, arterial remod-
eling and smooth muscle proliferation, wherass restenosis after stent im-
plantation is predominantly determined by neointimal proliferation. Hyperc-
holesterolemia is known to be a major risk factor for coronary artery disease,
but the association with neointimal proliferation has not been fully elucidated.
Therefore, the role of lipids on the development of restenosis after stent
placement has been investigated. We analyzed the association of serum
lipids with the development of restanosis (?50% diamater stanosis) of 750
lesions in 671 consecutive patients. They underwent successful stent implan-
tation between March 93 and March 96 and had repeat angiography after a
median of 191 days. For quantitative analysis an automated and computer
assisted edge detection method was used. Serum levels of total cholesterol,
LDL, HDL and Lp(a) were obtained at the time of the intervention and follow-
UPangiogram. There was no significant correlation of late lumen loss (mean:
1.1 + 0.03 mm) within the stantad segments or% restenosis (28.9%) and
the levels of total cholesterol, LDL, HDL and Lp(a), neither at the time of the
intervention nor at repeat angiogrephy.
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Extracorporal low density lipoprotein (LDL) elimination is frequently used
today for the treatment of drug-resistant hypercholesterolaemic patients.
One of the most specific apheresis methods, LDL-immunapheresla, was
daveloped to selectively remove LDL and lipoprotein (a) [Lp(a)] from plasma.
Since lipid peroxidation is one of the unwanted side effects of extracorporaal
plasma treatments, we followed the oxidative status of patiants treated with
LDL-immunapheresis. For this purpose lipid hydroperoxides, the primary
prcducts of lipid peroxidation and thiobarbituric acid-reacting substances
(TBARS), secondary products, were determined in 13 patients before, during
and after LDL-immunapheresis. The amount of plasma volume treated per
patient was 6164 + 546 ml. Treatment led to a reduction of total cholesterol
by89 +8%, of LDL-cholesterol by78.8 +7.3%, of HDL-cholesterol by 19.2 l
7.1% and of triglycerides by 37.6 + 21%. Apoiipoprotein-B, Lp(a) and apoAl
were reduced by 77.1 + 6.45%, 25 + 5.6% and 76.4 + 10.37., respectively.
Before treatment, mean plasma concentration of lipid hydroperoxides was
22.6 + 15.2 Kmol/L, whereas following treatment plasma hydroperoxides
were reduced to 6.9 + 7.4 Womol/L. This reduction of 64.7 & 27Y0 was
statistically highly significant (p < 0.001). Anon-significant change of TBARS
concentration from 0.30 + 0.26 Mmol/L to 0.23 + 0.13 wmol/L was also
obsarved. We conclude that LDL-immunapheresis is not only very effective
in reducing LDL- and Lp(a)-cholesterol, but also has a beneficial effect on
the oxidative status of the uatienta.
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Treatmentof hypercholesterolemiaforsecondary prevention ofoardiacevents
is now firmly established. Lipid levels remain valid for 24 hours after the onset
of myocerdial infarction (Ml) and 1994 national guideline recommend mea-
surement of serum lipids in patients (pts) within 24 hours in order to identify
those in need of therapy. We designed a housestaff education project to
alter physician behavior in obtaining lipid levels and treating elevated LDL-
cholesterol in pts with acute coronaw syndromes. The intervention consisted
of formal didactic sessions on lipid testing and twice-weekly reinforcement
sessiona on rounds by the medical chief resident, along with postad ra-
mindere in clinical areas. All pts with Ml during tha two month study period
(12/95-1/98) were identified by an alevated creatine kinase level and ela-
vatad MB fraction. Lipid testing and therapy rates were compared to a his-
torical control population (n= 280) admitted with acute coronav syndromes
over a previous recent 12 month period. Results:We identified 134 pte with
ML In pta for whom data was available, 35% had a history of hyperlipidemia,
of whom 469!. were on therapy at admission. SW5XVYPercent .of study Pts
compared to 45~oof controls (p = 0.0001) had lipid levels drawn at some
point during admission; 25%vs. 15% (p =0.03) had fasting panels by hospital
